menu search

Biomerica reports first quarter 2024 financial results

Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024 vs the first fiscal quarter of 2023 Company believes current cash...

October 13, 2023, 10:39 am

Toyota (tm) unites with idemitsu to make solid-state batteries

Toyota (TM) teams up with Idemitsu to achieve mass production of solid-state batteries for EVs....

October 13, 2023, 10:31 am

Bullish on clean energy? buy these 3 clean energy stocks now.

A signature achievement of the Inflation Reduction Act of 2022 was the billions of dollars in tax credi...

October 13, 2023, 5:40 am

Campbell soup: sovos acquisition gears up operations

Campbell Soup Company is looking to acquire Sovos Brands to improve its top line growth and expand its product offering, as well as to ...

October 13, 2023, 1:40 am

Leukemia therapeutics treatment market set to achieve us$ 30,318.5 million by 2033 at 7.1% cagr | future market insights inc.

Innovations in leukemia treatment require substantial investments, and larger companies with robust financial resources hold a dominant position in th...

October 12, 2023, 3:30 pm

Barrick achieves gold production growth in q3, but falls short of quarter projections

(Kitco News) - Barrick Gold (NYSE: GOLD) (TSX: ABX) announced Thursday that the company produced 1,039 koz of gold in Q3 2023, which is an increase of...

October 12, 2023, 12:22 pm

3 ev stocks that need to be on your october buy list

The competition in the Electric Vehicle industry is growing and while it is too soon to announce a winner, Tesla (NASDAQ: TSLA ) is still considered a...

October 12, 2023, 11:24 am

Viasat shares rocket on positive financial developments

Viasat shares took off after the satellite communications company said it expects to achieve positive f...

October 12, 2023, 11:06 am

Eli lilly stock hits new high on positive crohn's disease study results

Eli Lilly and Co (NYSE:LLY) announced on Thursday that its drug development candidate, mirikizumab, met the main goals of a late-stage study to test...

October 12, 2023, 8:35 am

Wise elevates fy24 outlook amid q2 figures: revenue, volume rise

Payments startup Wise (LON: WISE) closed the second quarter of the fiscal year 2024 with an annual increase of 22 percent in its revenue, elevating th...

October 12, 2023, 7:31 am

Boj's noguchi: we have no choice but to raise inflation forecast for fiscal year 2023

Inflation of this extent was unexpectedGrowth rates and inflation both deviating upwardlyBut inflation expectation does not factor in ...

October 12, 2023, 6:05 am

Buyw: stellar short-term performance may not be repeatable

Main Buywrite ETF opportunistically writes call options on a basket of various ETFs the manager deems to be attractive. BUYW ETF has outperformed in t...

October 12, 2023, 2:07 am

Wayfair: positive ebitda coupled with undervaluation, a formula for upside potential

Wayfair is a leading e-commerce platform specializing in home goods, offering customers a wide range of choices. Despite market challenges, Wayfair ha...

October 12, 2023, 1:01 am

Vertex energy: a hold with growing throughput volume and renewable diesel production

Vertex Energy has made progress in its renewable diesel project, with Q2 2023 revenues beating estimates and a focus on performance management for H2 ...

October 11, 2023, 5:45 pm

Bitcoin’s first ever evm transaction takes place paving way for zk rollup

The first Ethereum Virtual Machine transaction on bitcoin has been achieved, the latest milestone towar...

October 11, 2023, 4:14 pm

3 solar energy stocks to reap massive gains

The future of solar is bright and governments across the world are trying their best to achieve their g...

October 11, 2023, 3:37 pm

Akero (akro) slumps 63% on mixed results from nash study

Data from a mid-stage study shows that Akero Therapeutics' (AKRO) lead candidate failed to achieve stat...

October 11, 2023, 12:47 pm

Fabrinet's datacom business: a beacon of growth

While overall growth is stagnant, Fabrinet's datacom business segment is showing remarkable promise, with significant revenue growth. The stock's valu...

October 11, 2023, 12:01 pm

Patient with candida krusei infection in matinas biopharma’s oral mat2203 expanded access program achieves complete clinical resolution

BEDMINSTER, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on de...

October 11, 2023, 11:30 am

Gartner: strong recurring business model with double digit revenue growth

Gartner's Research business shows strong recurring growth, contributing over 80% of total revenue and increasing by 7% during the pandemic. The compan...

October 10, 2023, 10:09 pm


Search within

Pages Search Results: